Pomezia, Italy

Antonino Cattaneo

This inventor holds 1 USPTO granted patent. Top assignees: Pangenetics B.v., Scoula Internazionale Superiore Di Studi Avanzati. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonino Cattaneo. Retrieved from https://idiyas.com/inventor/antonino-cattaneo-vib3ey66

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonino Cattaneo: Innovator in Antibody Humanization

Introduction

Antonino Cattaneo is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of biotechnology, particularly in the humanization of antibodies. His work has implications for therapeutic applications, enhancing the efficacy of treatments.

Latest Patents

Cattaneo holds a patent for a "Method for the humanization of antibodies and humanized antibodies thereby obtained." This method focuses on the humanization of the VH and VL variable regions of an animal antibody of known sequence. The patent specifically addresses the creation of humanized animal antibodies, including anti-NGF and anti-TrkA humanized animal antibodies.

Career Highlights

Throughout his career, Antonino Cattaneo has worked with various organizations, including Pangenetics B.V. and Scuola Internazionale Superiore Di Studi Avanzati. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Cattaneo has collaborated with notable colleagues such as Doriano Lamba and Sonia Covaceuszach. These partnerships have further enriched his research endeavors and expanded the impact of his work.

Conclusion

Antonino Cattaneo's innovative approach to antibody humanization has positioned him as a key figure in biotechnology. His patent and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…